Journal ArticleCommun Med (Lond) · May 15, 2025
BACKGROUND: Sequential multivalent immunizations are used to counter diversity in rapidly mutating viruses. Here, we evaluated the effect of HIV-1 immunogen formats on the binding profile of memory B-cells elicited in two independent Rhesus macaque trials. ...
Full textLink to itemCite
Journal ArticleMucosal Immunol · April 2025
Dimeric IgA (dIgA) is the dominant antibody in many mucosal tissues. It is actively transported onto mucosal surfaces as secretory IgA (sIgA) which plays an integral role in protection against enteric pathogens, particularly in young children. Therapeutic ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · September 10, 2024
BACKGROUNDThe HIV Organ Policy Equity (HOPE) Act allows individuals living with HIV to accept organs from donors with HIV. This practice widens the pool of available organs, but also presents important virological issues, including the potential for HIV su ...
Full textLink to itemCite
Journal ArticleSci Immunol · July 12, 2024
Virus-induced cell death is a key contributor to COVID-19 pathology. Cell death induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is well studied in myeloid cells but less in its primary host cell type, angiotensin-converting enzyme 2 ...
Full textLink to itemCite
Journal ArticleViruses · November 14, 2023
Integrase defective lentiviral vectors (IDLVs) are a promising vaccine delivery platform given their ability to induce high magnitude and durable antigen-specific immune responses. IDLVs based on the simian immunodeficiency virus (SIV) are significantly mo ...
Full textLink to itemCite
Journal ArticleRetrovirology · March 16, 2023
Although antiretroviral therapy (ART) has increased life expectancy in people with HIV-1 (PWH), acute and chronic kidney disease remain common in this population and are associated with poor outcomes. A broad spectrum of kidney disorders can be observed in ...
Full textLink to itemCite
Journal ArticleImmunohorizons · December 1, 2022
The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease (COVID-19) has led to a pandemic of unprecedented scale. An intriguing feature of the infection is the minimal disease in most children ...
Full textLink to itemCite
Journal ArticleJ Virol · July 27, 2022
HIV-1 persistence in different cell types presents the main obstacle to an HIV-1 cure. We have previously shown that the renal epithelium is a site of HIV-1 infection and that the kidney represents a separate viral compartment from blood. Whether renal cel ...
Full textLink to itemCite
Journal ArticleNPJ Vaccines · July 4, 2022
Vaccines represent the single most cost-efficient and equitable way to combat and eradicate infectious diseases. While traditional licensed vaccines consist of either inactivated/attenuated versions of the entire pathogen or subunits of it, most novel expe ...
Full textLink to itemCite
Journal ArticleCell Host Microbe · May 11, 2022
The maternal immune system protects developing offspring against pathogens before birth via transplacental transfer and after birth through secreted milk. This transferred maternal immunity influences each generation's susceptibility to infections and resp ...
Full textLink to itemCite
Journal ArticleNPJ Vaccines · April 21, 2022
Integrase Defective Lentiviral Vectors (IDLVs) represent an attractive vaccine platform for delivering HIV-1 antigens, given their ability to induce specific and persistent immune responses in both mice and non-human primates (NHPs). Recent advances in HIV ...
Full textLink to itemCite
Journal ArticleCell Death Discov · February 15, 2022
Diacetyl (DA) is an α-diketone that is used to flavor microwave popcorn, coffee, and e-cigarettes. Occupational exposure to high levels of DA causes impaired lung function and obstructive airway disease. Additionally, lower levels of DA exposure dampen hos ...
Full textLink to itemCite
Journal ArticleFront Cell Dev Biol · 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the Coronavirus disease 2019 (COVID-19), which has resulted in over 5.9 million deaths worldwide. While cells in the respiratory system are the initial target of SARS-CoV-2, there is mount ...
Full textOpen AccessLink to itemCite
Journal ArticleiScience · December 17, 2021
Currently available SARS-CoV-2 therapeutics are targeted toward moderately to severely ill patients and require intravenous infusions, with limited options for exposed or infected patients with no or mild symptoms. Although vaccines have demonstrated prote ...
Full textLink to itemCite
Journal ArticlebioRxiv · November 17, 2021
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the Coronavirus disease 2019 (COVID-19), which was declared a pandemic by the World Health Organization (WHO) in March 2020. The disease has caused more than 5.1 million deaths ...
Full textLink to itemCite
Journal ArticleAIDS · March 1, 2021
Featured Publication
People living with HIV are at higher risk for acute and chronic kidney disease compared with uninfected individuals. Kidney disease in this population is multifactorial, with several contributors including HIV infection of kidney cells, chronic inflammatio ...
Full textLink to itemCite
Journal ArticleNPJ Vaccines · November 18, 2020
Featured Publication
A preventative HIV-1 vaccine is an essential intervention needed to halt the HIV-1 pandemic. Neutralizing antibodies protect against HIV-1 infection in animal models, and thus an approach toward a protective HIV-1 vaccine is to induce broadly cross-reactiv ...
Full textLink to itemCite
Journal ArticleMedicine (Baltimore) · November 13, 2020
Featured Publication
HIV-1 persists indefinitely in multiple cellular reservoirs despite antiretroviral therapy. We previously demonstrated HIV-1 compartmentalization in kidney and urine. Here, we further characterized viruses in urine and when available, compared them to thos ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · November 5, 2020
Featured Publication
The current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), reveals a peculiar trend of milder disease and lower case fatality in children compared with adults. Consisten ...
Full textLink to itemCite
Journal ArticlePLoS Pathog · November 2020
Rotavirus (RV) vaccine efficacy is significantly reduced in lower- and middle-income countries (LMICs) compared to high-income countries. This review summarizes current research into the mechanisms behind this phenomenon, with a particular focus on the evi ...
Full textLink to itemCite
Journal ArticleAIDS · September 1, 2020
Featured Publication
OBJECTIVES: HIV-1 can infect and persist in different organs and tissues, resulting in the generation of multiple viral compartments and reservoirs. Increasing evidence supports the kidney as such a reservoir. Previous work demonstrated that HIV-1 infected ...
Full textLink to itemCite
Journal ArticleMol Ther Methods Clin Dev · June 12, 2020
We previously developed integrase-defective lentiviral vectors (IDLVs) as an antigen delivery system for inducing strong and prolonged immunity in animal models. Here, we examined the association between persistence of antigen expression and durability of ...
Full textLink to itemCite
Journal ArticleNPJ Vaccines · May 8, 2020
Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. ...
Full textLink to itemCite
Journal Article · 2020
Featured Publication
A preventative HIV-1 vaccine is an essential intervention needed to halt the HIV-1 pandemic. Neutralizing antibodies protect against HIV-1 infection in animal models, and thus an approach toward a protective HIV-1 vaccine is to induce broadly cross-reactiv ...
Full textCite
Journal ArticleNPJ Vaccines · 2020
Featured Publication
Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of therapy. ...
Full textLink to itemCite
Journal ArticleNature · May 2019
Featured Publication
Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) are pathologically activated neutrophils that are crucial for the regulation of immune responses in cancer. These cells contribute to the failure of cancer therapies and are associated with poo ...
Full textLink to itemCite
Journal ArticleCommun Biol · 2018
Featured Publication
HIV continues to be a major global health issue. In spite of successful prevention interventions and treatment methods, the development of an HIV vaccine remains a major priority for the field and would be the optimal strategy to prevent new infections. We ...
Full textOpen AccessLink to itemCite
Journal ArticleNat Commun · December 14, 2017
Featured Publication
Cross-presentation is a critical function of dendritic cells (DCs) required for induction of antitumor immune responses and success of cancer immunotherapy. It is established that tumor-associated DCs are defective in their ability to cross-present antigen ...
Full textLink to itemCite
Journal ArticleMol Ther · November 2016
Featured Publication
The design of an effective HIV-1 vaccine remains a major challenge. Several vaccine strategies based on viral vectors have been evaluated in preclinical and clinical trials, with largely disappointing results. Integrase defective lentiviral vectors (IDLV) ...
Full textOpen AccessLink to itemCite
Journal ArticleAIDS · August 24, 2015
Featured Publication
OBJECTIVE: HIV-1 persists indefinitely in memory CD4 T cells and other long-lived cellular reservoirs despite antiretroviral therapy. Our group had previously demonstrated that HIV-1 can establish a productive infection in renal epithelial cells and that t ...
Full textLink to itemCite
Journal ArticleViral Immunol · December 2014
As a prelude to immunization studies in nonhuman primates, we compared in mice the immunogenicity of a simian immunodeficiency virus (SIV)-based integrase (IN)-defective lentiviral vector (IDLV) encoding the model antigen-enhanced green fluorescence protei ...
Full textLink to itemCite
Journal ArticleAIDS · October 23, 2014
Featured Publication
OBJECTIVES: Increasing evidence supports the role of the kidney as a reservoir for HIV-1. In-vitro co-cultivation of HIV-infected T cells with renal tubule epithelial (RTE) cells results in virus transfer to the latter, whereas cell-free virus infection is ...
Full textLink to itemCite
Journal ArticleInfection · August 2014
PURPOSE: Human immunodeficiency virus (HIV-1)-infected patients frequently harbour hepatitis B and C viruses (HBV and HCV, respectively). Possible modifications of the natural history of hepatitis B may occur. The aim of this study was to characterise HBV ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
Many infectious agents infiltrate the host at the mucosal surfaces and then spread systemically. This implies that an ideal vaccine should induce protective immune responses both at systemic and mucosal sites to counteract invasive mucosal pathogens. We ev ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · October 2013
Although 2-long terminal repeat (2-LTR) circles are only a fraction of the total viral DNA in infected cells, sequence analysis of 2-LTR circles reveals critical information regarding viral DNA synthesis and the nature of actively replicating virus. It was ...
Full textLink to itemCite
Journal ArticleRetrovirology · August 22, 2012
BACKGROUND: Integrase defective lentiviral vectors (IDLV) represent a promising delivery system for immunization purposes. Human dendritic cells (DC) are the main cell types mediating the immune response and are readily transduced by IDLV, allowing effecti ...
Full textLink to itemCite
Journal ArticleExpert Opin Biol Ther · June 2011
INTRODUCTION: The development of new strategies for the induction of potent and broad immune responses is of high priority in the vaccine field. In this setting, integrase-defective lentiviral vectors (IDLV) represent a new and promising delivery system fo ...
Full textLink to itemCite